載入中
NYSEHealthcareMedical - Pharmaceuticals
最新資料
US$49.00
+US$0.77 · +1.60%
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
前收盤價
US$49.00
+US$0.77 · +1.60%
盤前
US$48.50
−US$0.50 · -1.02%
10月13日 上午4:38 ET
盤中時間採用ET。市場資料可能有所延遲。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日內區間
目前US$49.00
52週區間
目前US$49.00
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
83
深度低估
情緒
52
多空交錯
風險
42
風險偏高
動能
30
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日內區間
目前US$49.00
52週區間
目前US$49.00
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 10.89億 USD | 11.38億 USD | 11.25億 USD | 11.28億 USD | 10.87億 USD |
| 銷貨成本 | 5.14億 USD | 5.03億 USD | 5.01億 USD | 5.02億 USD | 4.66億 USD |
| 毛利 | 5.75億 USD | 6.34億 USD | 6.24億 USD | 6.25億 USD | 6.21億 USD |
| 銷售、一般及管理費用 | 2.65億 USD | 2.64億 USD | 2.59億 USD | 2.52億 USD | 2.65億 USD |
| 營業費用 | 2.65億 USD | 2.98億 USD | 2.82億 USD | 6.48億 USD | 2.91億 USD |
| 利息支出 | 4233.9萬 USD | 4763.2萬 USD | 6716萬 USD | 6916.4萬 USD | 6428.7萬 USD |
| 折舊和攤銷 | 3127.3萬 USD | 3017.3萬 USD | 3067.5萬 USD | 3262.5萬 USD | 3209.2萬 USD |
| 營業利益 | 3.09億 USD | 3.37億 USD | 3.42億 USD | −2241.5萬 USD | 3.3億 USD |
| 淨利 | 1.9億 USD | 2.15億 USD | 2.09億 USD | −8230.6萬 USD | 2.05億 USD |
公司資料更新於 2026年10月13日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI7846.7萬0.00%2.3兆 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM6014.81萬0.08%787.4億 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB5635.89萬0.03%1853億 USD0.03%US$288.16-0.46%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4004.74萬0.15%268.09億 USD0.33%US$37.98+0.08%
Vanguard Morningstar Small-Cap Value ETFVBR3584.28萬0.05%682億 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF2847.02萬0.03%954億 USD0.05%US$233.52-0.63%
Dimensional - US Targeted Value ETFDFAT2126.65萬0.07%301.22億 USD0.33%US$67.42+0.22%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM2104.34萬0.13%157.12億 USD0.03%US$53.42-0.06%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
